Anavex Life Sciences Corp AVXL.O:
ANAVEX LIFE SCIENCES PROVIDES UPDATE ON REGULATORY REVIEW IN THE EU FOR BLARCAMESINE TO TREAT EARLY ALZHEIMER’S DISEASE
ANAVEX LIFE SCIENCES CORP - WITHDRAWS EU MARKETING AUTHORIZATION APPLICATION FOR BLARCAMESINE
ANAVEX LIFE SCIENCES CORP - REMAINS COMMITTED TO CLINICAL DEVELOPMENT OF BLARCAMESINE FOR EARLY ALZHEIMER'S